CYCLERION THERAPEUTICS INC (CYCN) Stock News

Looking Into Cyclerion Therapeutics's Recent Short Interest

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion is leveraging its legacy sGC stimulator assets to generate near-term revenues which will be used to implement its strategic building plan....

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Regina Graul, Ph.D., has been promoted to Chief Executive Officer, President, and member of the Board of Directors of Cyclerion....

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024

Cyclerion Therapeutics just reported results for the first quarter of 2024.

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

Cyclerion Therapeutics just reported results for the fourth quarter of 2023.

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quart...

Cyclerion Appoints Regina Graul, Ph.D., as President

Cyclerion Appoints Regina Graul, Ph.D., as President

– Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep...

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in neurological and psychiatric disorders

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

        – Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment – – Tisento Developing Zagociguat in...